A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations (Q27321020)
Jump to navigation
Jump to search
scientific article (publication date: 2016)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations |
scientific article (publication date: 2016) |
Statements
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations (English)
0 references
2016
0 references
11
0 references
2
0 references
e0149610
0 references
22 February 2016
1 reference
1 reference
1 reference
1 reference